PTC Therapeutics to Host Conference Call to Discuss First Quarter 2022 Financial Results

Rhea-AI Summary

PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webcast conference call on May 3, 2022, at 4:30 p.m. ET to discuss its first quarter 2022 financial results and provide a business update. Investors can join the call by dialing (877) 303-9216 in the U.S. or (973) 935-8152 outside the U.S. A live webcast will be available on the company's investor website. PTC is focused on developing medicines for rare disorders and aims to maximize value for patients and stakeholders.

Positive

• Scheduled webcast for Q1 2022 financial results on May 3, 2022.
• Strong commitment to developing medicines for rare disorders.

Negative

• None.

SOUTH PLAINFIELD, N.J., April 19, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its first quarter 2022 financial results and provide an update on the company's business and outlook on Tuesday, May 3, at 4:30 p.m. ET.

The call can be accessed by dialing (877) 303-9216 (in the United States) or (973) 935-8152 (outside of the United States) five minutes prior to the start of the call and providing the passcode 9963177. A live, listen-only webcast of the conference call can be accessed on the investor section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days following the call.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-first-quarter-2022-financial-results-301525901.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics report its Q1 2022 financial results?

PTC Therapeutics will report its Q1 2022 financial results on May 3, 2022.

How can I access the webcast for PTC's Q1 2022 financial results?

You can access the webcast by visiting the investor section of PTC's website or by dialing (877) 303-9216 in the U.S.

What is the significance of the conference call on May 3, 2022?

The conference call will provide insights into PTC Therapeutics' financial performance and business outlook for Q1 2022.

What is PTC Therapeutics' focus area?

PTC Therapeutics focuses on the discovery and development of medicines for patients with rare disorders.